NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Kirsten Bibbins-Domingo et al.   ANNALS OF INTERNAL MEDICINE

Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

(2016) Marie C. Bradley et al.   CANCER

Metastasis: an early event in cancer progression

(2016) Yijun Hu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation

(2016) Wu-Tao Zeng et al.   MEDICINE

Metastatic colonization by circulating tumour cells

(2016) Joan Massagué et al.   NATURE

Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

(2016) Pete T. T. Kinnunen et al.   Scandinavian Journal of Urology

Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients

(2016) James L. Araujo et al.   Therapeutic Advances in Gastroenterology

Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies

(2016) Peter C. Elwood et al.   PLoS One

Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis

(2015) Xuan-zhang Huang et al.   CANCER CAUSES & CONTROL

Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer

(2015) Tatiana V Macfarlane et al.   Cancer Epidemiology

Oxidative stress inhibits distant metastasis by human melanoma cells

(2015) Elena Piskounova et al.   NATURE

Low-dose aspirin use and the risk of ovarian cancer in Denmark

(2014) L. Baandrup et al.   ANNALS OF ONCOLOGY

Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study

(2014) E. H. Allott et al.   BREAST CANCER RESEARCH AND TREATMENT

Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy

(2014) Corbin D Jacobs et al.   CANCER BIOLOGY & THERAPY

Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I-III Breast Cancer: A Nationwide Population-Based Cohort Study

(2014) T. I. Barron et al.   CANCER RESEARCH

NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin-Aromatase Interactions

(2014) L. W. Bowers et al.   CANCER RESEARCH

Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma

(2014) KAI CHEN et al.   ONCOLOGY REPORTS

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

(2013) Patrice Forget et al.   ANNALS OF SURGICAL ONCOLOGY

Low-dose aspirin use and cancer characteristics: a population-based cohort study

(2013) F Jonsson et al.   BRITISH JOURNAL OF CANCER

Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis

(2013) Rickard Ljung et al.   INTERNATIONAL JOURNAL OF CANCER

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality

(2012) C. McCowan et al.   EUROPEAN JOURNAL OF CANCER

Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy

(2012) Kevin S. Choe et al.   JOURNAL OF CLINICAL ONCOLOGY

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?

(2011) Hiroki Yuhara et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

(2011) Linda M. Liao et al.   GASTROENTEROLOGY

Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk

(2010) C. A. Salinas et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Inflammation: A driving force speeds cancer metastasis

(2010) Yadi Wu et al.   CELL CYCLE

Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006

(2010) Preet K. Dhillon et al.   INTERNATIONAL JOURNAL OF CANCER

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors

(2009) Matias E. Valsecchi et al.   Clinical Breast Cancer

Systemic Spread Is an Early Step in Breast Cancer

(2008) Yves Hüsemann et al.   CANCER CELL